{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:07:07Z","timestamp":1792681627348,"version":"4.5.0"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Detection of ductal carcinoma in situ (DCIS) by mammography screening is a controversial outcome with potential benefits and harms. The association of mammography screening interval and woman\u2019s risk factors with the likelihood of DCIS detection after multiple screening rounds is poorly understood.<\/jats:p><\/jats:sec>Objective<\/jats:title>To develop a 6-year risk prediction model for screen-detected DCIS according to mammography screening interval and women\u2019s risk factors.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This Breast Cancer Surveillance Consortium cohort study assessed women aged 40 to 74 years undergoing mammography screening (digital mammography or digital breast tomosynthesis) from January 1, 2005, to December 31, 2020, at breast imaging facilities within 6 geographically diverse registries of the consortium. Data were analyzed between February and June 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Screening interval (annual, biennial, or triennial), age, menopausal status, race and ethnicity, family history of breast cancer, benign breast biopsy history, breast density, body mass index, age at first birth, and false-positive mammography history.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Screen-detected DCIS defined as a DCIS diagnosis within 12 months after a positive screening mammography result, with no concurrent invasive disease.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 916\u202f931 women (median [IQR] age at baseline, 54 [46-62] years; 12% Asian, 9% Black, 5% Hispanic\/Latina, 69% White, 2% other or multiple races, and 4% missing) met the eligibility criteria, with 3757 screen-detected DCIS diagnoses. Screening round\u2013specific risk estimates from multivariable logistic regression were well calibrated (expected-observed ratio, 1.00; 95% CI, 0.97-1.03) with a cross-validated area under the receiver operating characteristic curve of 0.639 (95% CI, 0.630-0.648). Cumulative 6-year risk of screen-detected DCIS estimated from screening round\u2013specific risk estimates, accounting for competing risks of death and invasive cancer, varied widely by all included risk factors. Cumulative 6-year screen-detected DCIS risk increased with age and shorter screening interval. Among women aged 40 to 49 years, the mean 6-year screen-detected DCIS risk was 0.30% (IQR, 0.21%-0.37%) for annual screening, 0.21% (IQR, 0.14%-0.26%) for biennial screening, and 0.17% (IQR, 0.12%-0.22%) for triennial screening. Among women aged 70 to 74 years, the mean cumulative risks were 0.58% (IQR, 0.41%-0.69%) after 6 annual screens, 0.40% (IQR, 0.28%-0.48%) for 3 biennial screens, and 0.33% (IQR, 0.23%-0.39%) after 2 triennial screens.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study, 6-year screen-detected DCIS risk was higher with annual screening compared with biennial or triennial screening intervals. Estimates from the prediction model, along with risk estimates of other screening benefits and harms, could help inform policy makers\u2019 discussions of screening strategies.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.0166","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:10:22Z","timestamp":1676909422000},"page":"e230166","source":"Crossref","is-referenced-by-count":3,"title":["Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency"],"prefix":"10.1001","volume":"6","author":[{"given":"Brian L.","family":"Sprague","sequence":"first","affiliation":[{"name":"Office of Health Promotion Research, University of Vermont, Burlington"},{"name":"Department of Surgery, University of Vermont, Burlington"},{"name":"University of Vermont Cancer Center, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Miglioretti","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California, Davis"},{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C.","family":"Gard","sequence":"additional","affiliation":[{"name":"Department of Economics, Applied Statistics, and International Business, New Mexico State University, Las Cruces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Tice","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Aiello Bowles","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, University of Vermont Cancer Center, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"},{"name":"General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"15","key":"zoi230016r1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/jama.2009.1498","article-title":"Rethinking screening for breast cancer and prostate cancer.","volume":"302","author":"Esserman","year":"2009","journal-title":"JAMA"},{"issue":"9855","key":"zoi230016r2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review.","volume":"380","author":"Independent UK Panel on Breast Cancer Screening","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"zoi230016r3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016161174","article-title":"National Performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium.","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"key":"zoi230016r4","doi-asserted-by":"publisher","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"zoi230016r5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1470-2045(15)00446-5","article-title":"Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.","volume":"17","author":"Duffy","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"zoi230016r6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamaoncol.2015.4096","article-title":"Mammography screening and overdiagnosis.","volume":"2","author":"Nelson","year":"2016","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi230016r7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.7326\/M15-1536","article-title":"Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies.","volume":"164","author":"Mandelblatt","year":"2016","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi230016r8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.7326\/0003-4819-158-11-201306040-00008","article-title":"Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.","volume":"158","author":"Etzioni","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi230016r9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7326\/M21-3577","article-title":"Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort.","volume":"175","author":"Ryser","year":"2022","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi230016r10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"15","key":"zoi230016r11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"issue":"14","key":"zoi230016r12","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1002\/cncr.v126.14","article-title":"New mammography screening performance metrics based on the entire screening episode.","volume":"126","author":"Sprague","year":"2020","journal-title":"Cancer"},{"issue":"10","key":"zoi230016r13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.7326\/M16-0476","article-title":"Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes.","volume":"165","author":"Trentham-Dietz","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi230016r14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","article-title":"Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.","volume":"164","author":"Cintolo-Gonzalez","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"zoi230016r15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnci\/djac008","article-title":"Cumulative advanced breast cancer risk prediction model developed in a screening mammography population.","volume":"114","author":"Kerlikowske","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi230016r16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2440","article-title":"Cumulative probability of false-positive results after 10 years of screening with digital breast tomosynthesis vs digital mammography.","volume":"5","author":"Ho","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi230016r17","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi230016r19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease.","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi230016r20","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study.","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"9352","key":"zoi230016r21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","article-title":"Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.","volume":"361","author":"Page","year":"2003","journal-title":"Lancet"},{"issue":"28","key":"zoi230016r22","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer.","volume":"33","author":"Tice","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"zoi230016r23","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model.","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"zoi230016r24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1055-9965.EPI-15-0824","article-title":"Statistical methods for estimating the cumulative risk of screening mammography outcomes.","volume":"25","author":"Hubbard","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"zoi230016r27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaoncol.2015.3084","article-title":"Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status.","volume":"1","author":"Miglioretti","year":"2015","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi230016r28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question.","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"41","key":"zoi230016r30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"zoi230016r31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi230016r32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial.","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"32","key":"zoi230016r33","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"issue":"32","key":"zoi230016r34","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.","volume":"32","author":"W\u00e4rnberg","year":"2014","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi230016r35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ.","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi230016r36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaoncol.2015.2607","article-title":"Rethinking the standard for ductal carcinoma in situ treatment.","volume":"1","author":"Esserman","year":"2015","journal-title":"JAMA Oncol"},{"issue":"10","key":"zoi230016r37","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/S1470-2045(16)30367-9","article-title":"Treatment of low-risk ductal carcinoma in situ: is nothing better than something?","volume":"17","author":"Benson","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"zoi230016r38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamaoncol.2015.5026","article-title":"Overtreatment of low-grade ductal carcinoma in situ.","volume":"2","author":"Fallowfield","year":"2016","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi230016r39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clon.2014.09.015","article-title":"The LORIS Trial: addressing overtreatment of ductal carcinoma in situ.","volume":"27","author":"Francis","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"zoi230016r40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ: the LORD study.","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"zoi230016r41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"8","key":"zoi230016r42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jnci\/djaa218","article-title":"Trade-offs between harms and benefits of different breast cancer screening intervals among low-risk women.","volume":"113","author":"van Ravesteyn","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"zoi230016r43","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0959-8049(03)00260-0","article-title":"Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.","volume":"39","author":"Yen","year":"2003","journal-title":"Eur J Cancer"},{"issue":"1_suppl","key":"zoi230016r44","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1177\/0272989X17729358","article-title":"Modeling ductal carcinoma in situ (DCIS): an overview of CISNET model approaches.","volume":"38","author":"van Ravesteyn","year":"2018","journal-title":"Med Decis Making"},{"issue":"21","key":"zoi230016r45","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence.","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi230016r46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10552-019-01253-4","article-title":"Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.","volume":"31","author":"Puvanesarajah","year":"2020","journal-title":"Cancer Causes Control"},{"issue":"41","key":"zoi230016r47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ.","volume":"2010","author":"Kerlikowske","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"zoi230016r48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101648","article-title":"Risk factors for ductal carcinoma in situ of the breast in the UK Biobank cohort study.","volume":"64","author":"Peila","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"zoi230016r49","first-page":"697","article-title":"Risk factors for carcinoma in situ of the breast.","volume":"9","author":"Trentham-Dietz","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"zoi230016r50","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1158\/1055-9965.EPI-15-0623","article-title":"Increased risk of developing breast cancer after a false-positive screening mammogram.","volume":"24","author":"Henderson","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi230016r51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41416-018-0358-5","article-title":"Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.","volume":"120","author":"Rom\u00e1n","year":"2019","journal-title":"Br J Cancer"},{"issue":"2","key":"zoi230016r52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1148\/radiol.2020191751","article-title":"Five consecutive years of screening with digital breast tomosynthesis: outcomes by screening year and round.","volume":"295","author":"Conant","year":"2020","journal-title":"Radiology"},{"issue":"5","key":"zoi230016r53","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamaoncol.2018.7078","article-title":"Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density.","volume":"5","author":"Conant","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi230016r54","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11792","article-title":"Screening performance of digital breast tomosynthesis vs digital mammography in community practice by patient age, screening round, and breast density.","volume":"3","author":"Lowry","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi230016r55","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djy121","article-title":"Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall.","volume":"110","author":"Marinovich","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi230016r56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1759","article-title":"Assessment of radiologist performance in breast cancer screening using digital breast tomosynthesis vs digital mammography.","volume":"3","author":"Sprague","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi230016r57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2021.01.035","article-title":"Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening.","volume":"148","author":"Houssami","year":"2021","journal-title":"Eur J Cancer"},{"issue":"24","key":"zoi230016r58","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.2014.6095","article-title":"Breast cancer screening using tomosynthesis in combination with digital mammography.","volume":"311","author":"Friedewald","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"zoi230016r59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1148\/radiol.2021203936","article-title":"Interval and subsequent round breast cancer in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography screening.","volume":"300","author":"Hofvind","year":"2021","journal-title":"Radiology"},{"issue":"12","key":"zoi230016r60","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/oxfordjournals.aje.a117592","article-title":"A critical look at methods for handling missing covariates in epidemiologic regression analyses.","volume":"142","author":"Greenland","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"22","key":"zoi230016r61","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","article-title":"Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.","volume":"95","author":"Kerlikowske","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"zoi230016r18","unstructured":"American College of Radiology. ACR BI-RADS\u2014Mammography. 5th ed. ACR BI-RADS Atlas: Breast Imaging Reporting and Data System. American College of Radiology; 2013. Accessed January 18, 2023. https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/Bi-Rads"},{"key":"zoi230016r25","unstructured":"US Census Bureau. Annual Estimates of the Resident Population by Sex: Single Year of Age, Race, and Hispanic Origin for the United States. US Census Bureau; 2017. Accessed May 27, 2019. https:\/\/www2.census.gov\/programs-surveys\/popest\/datasets\/2010-2017\/national\/asrh\/"},{"key":"zoi230016r26","unstructured":"National Center for Health Statistics. 2015 National Health Interview Survey. National Center for Health Statistics; 2015. Accessed January 18, 2023. https:\/\/www.cdc.gov\/nchs\/nhis\/nhis_2015_data_release.htm"},{"key":"zoi230016r29","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. National Comprehensive Cancer Network; 2021. Accessed January 18, 2023. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2801644\/sprague_2023_oi_230016_1676273917.48879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:10:46Z","timestamp":1676909446000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2801644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0166","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}